IP Library Granted Patent US 11,123,273
Granted Patent B1
US 11,123,273 · App. 16/939,854 · Granted Sep 21, 2021

Method for providing bactericidal and bacteriostatic activity with a biosolvent formulation

Inventors: Rathin Datta (Chicago, IL); George Dymond Laubach (Elgin, IL); James E. Opre (Downers Grove, IL)
Assignee: VERTEC BIOSOLVENTS, INC.
A61K8/37A61K8/34A61K8/345A61K8/678A61K8/731A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,123,273
App. No.
16/939,854
Granted
Sep 21, 2021
Kind
B1
Abstract

A biosolvent for cleansing surface that provides bactericidal and bacteriostatic activity such that the bacteriostatic activity continues to inhibit bacterial growth on the surface even after rinsing. The biosolvent comprises C2 to C4 alcohols and lactate esters of C2 to C4 alcohols. The bactericidal and bacteriostatic activity are especially useful for cleaning active biological surfaces and in particular for sanitizing hands.

Claims (12)

1. A method for sanitizing human skin with a biosolvent mixture that provides bactericidal activity and also provides bacteriostatic activity wherein the bacteriostatic activity remains when the biosolvent mixture is in the presence of water, the method comprising: contacting the human skin with a biosolvent mixture comprising at least 60 wt. % of at least one C 2 to C 4 alcohol and at least 10 wt. % of at least one lactate ester of a C 2 to C 4 alcohol and without the addition of extrinsic water at the time of contacting to kill bacterial contaminants and to leave a residue of the biosolvent mixture on the human skin and to produce a cleansed condition that continues to provide the bacteriostatic activity.

2. The method of claim 1 wherein the human skin includes human hands.

3. The method of claim 1 wherein the biosolvent mixture further comprises on a wt./wt. % basis 3 to 5% glycerol.

4. The method of claim 1 wherein the biosolvent mixture further contains a viscosifier.

5. The method of claim 4 wherein the viscosifier comprises a cellulose ester.

6. The method of claim 1 wherein the biosolvent mixture further contains from 1 to 2 wt. % of an organic acid.

7. The method of claim 1 wherein the lactate ester is ethyl lactate and the alcohol is ethanol.

8. The method of claim 1 wherein the biosolvent mixture comprises on a wt./wt. % basis 70 to 80% ethanol and 15 to 25% ethyl lactate.

9. The method of claim 1 wherein the biosolvent mixture provides bactericidal activity that kills at least 99.99% of the bacterial contamination from the human skin.

10. The method of claim 1 wherein the biosolvent mixture further comprises on a (wt./wt.) basis a total of 1% to 5% of at least one of Vitamin E and a fragrance.

11. The method of claim 1 wherein only intrinsic water from the hand is present when contacting the human skin with the biosolvent mixture.

12. The method of claim 1 wherein only intrinsic water is present when contacting the human skin with the biosolvent mixture.

Assignments (2)
SECURITY INTEREST Recorded Jul 10, 2026
From: VERTEC BIOSOLVENTS, INC.
To: SILVER POINT FINANCE, LLC
Reel/Frame 075232/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2021
From: DATTA, RATHIN; LAUBACH, GEORGE DYMOND; OPRE, JAMES E.
To: VERTEC BIOSOLVENTS, INC.
Reel/Frame 056943/0014 →